Amanta Healthcare Ltd.

100.72

0.3 (0.3%)growUp

As on March 6, 2026
Sector
IndustryPharmaceuticals & Biotechnology
Basic IndustryPharmaceuticals
Market Cap0 Cr
P/E Ratio27.65
Dividend YieldN/A
Trendline Performance
TradingView Logo

We are partnered with TradingView to provide dynamic charts and powerful tools for market analysis.

Unlock_ipo_icon.webpUnlock Stock of the Month

T&C*

Company Information


Market Insights
Open100.05
High101.5
NSE SymbolAMANTA
Close100.72
Low99.55
BSE Symbol544502
Previous Years High/Low
1 Year High154.4
3 Year High154.4
5 Year High154.4
1 Year Low97.75
3 Year Low97.75
5 Year Low97.75

Technicals


IndicatorsValueSignal
5-DMA100.76Bearish
10-DMA102.05Bearish
20-DMA104.2Bearish
50-DMA105.23Bearish
100-DMA110.4Bearish
200-DMA---

Historical Performance


1 Year
N/A
3 Years
N/A
5 Years
N/A
10 Years
N/A

Shareholding Pattern


Values Analysis


Loading chart...

Profit & Loss

Below figures are in Rs. Crores


Compounded Sales Growth
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Compounded Profit Growth
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Stock Price CAGR
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Return on Equity
10 Years:N/A
5 Years:N/A
3 Years:N/A
last year:N/A

Quarterly Results

Below figures are in Rs. Crores


ParticularsSep-2024Dec-2024Mar-2025Jul-2025Sep-2025
Sales1,70,7541,35,9361,28,5521,22,1891,05,161
Expenses63,04256,55752,45745,45934,856
Operating Profit1,07,71279,37976,09676,73070,304
OPM %63%58%59%63%67%
Other Income33,91231,75927,33324,87918,947
Interest77,78058,58459,24862,13753,713
Depreciation2,3451,6811,3851,2771,221
Profit Before Tax61,49850,87342,79638,19534,318
Tax %25%25%26%29%35%
Net Profit46,14938,15131,85727,29622,446
EPS in Rs8369585042

Balance Sheet

Below figures are in Rs. Crores


0%
Positive
(80 to 100)
Neutral
(60 to 79)
Negative
(0 to 59)
  • The stock has a high PE of 27.65, indicating expensive valuation or elevated growth expectations.
  • Over the last three years, the stock delivered price CAGR data is unavailable.
  • The stock carries a beta of 1.2, indicating volatility broadly in line with the market.
  • In the last financial year, the company reported an EBITDA of ₹611 million, reflecting positive operating performance.
  • In the previous financial year, the company generated revenue of ₹2747 million, suggesting a mid-sized operation.

Investment Calculator


Investment Amount:

Investment Amount: ₹ 1000000
Current Value: ₹ 710546.7
No. of Shares: 7055 (Approx)
Performance:-28.9%
P/L: ₹-289453.3
NIFTY Performance: 8.4%
1 day Top Gainers
SymbolChange%
JWL298.6(17%)
KIRLOSBROS1645.7(10%)
IRCON146.95(10%)
RADICO2766.9(8%)
UBL1758.2(7%)
1 Day Top Losers
SymbolChange%
LTFOODS393.5(-9%)
TEJASNET465.05(-6%)
MANYAVAR366.9(-5%)
GODREJPROP1667.3(-4%)
MGL1049.3(-4%)
COHANCE279.9(-4%)
ASHOKLEY194.67(-4%)
SUNDARMFIN5356(-4%)

Top Performing Stocks from the same sector


Ortin Global Ltd.

35.2%

16.96

1 Month Performance

Lincoln Pharmaceuticals Ltd.

34.1%

616.75

1 Month Performance

Onesource Specialty Pharma Ltd.

32.2%

1480.5

1 Month Performance

Natco Pharma Ltd.

23.8%

1019.7

1 Month Performance

Sai Life Sciences Ltd.

22%

1037

1 Month Performance

Sakar Healthcare Ltd.

20.7%

527.95

1 Month Performance

SMS Pharmaceuticals Ltd.

18.2%

375.75

1 Month Performance

Bliss GVS Pharma Ltd.

16.8%

213.89

1 Month Performance

Get Your Portfolio Reviewed

Stock of the Month
Stock of the Month